Aurobindo Pharma receives USFDA approval for Cephalexin Tablets
The product is expected to be launched in Q3FY25
The product is expected to be launched in Q3FY25
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The inspection concluded with the issuance of a form 483 with five observations
The net-zero target approval complements the company's near-term emission reduction targets
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The company will also share results in two additional posters for deuruxolitinib
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Subscribe To Our Newsletter & Stay Updated